solifenacin succinate + tamsulosin + placebo
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Urinary Incontinence
Conditions
Urinary Incontinence
Trial Timeline
May 1, 2006 → Jan 1, 2007
NCT ID
NCT00333112About solifenacin succinate + tamsulosin + placebo
solifenacin succinate + tamsulosin + placebo is a approved stage product being developed by Astellas Pharma for Urinary Incontinence. The current trial status is completed. This product is registered under clinical trial identifier NCT00333112. Target conditions include Urinary Incontinence.
What happened to similar drugs?
20 of 20 similar drugs in Urinary Incontinence were approved
Approved (20) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00333112 | Approved | Completed |
Competing Products
20 competing products in Urinary Incontinence